Trabectedin Clinical Trials
8 recruitingDrug
Phase 27Phase 12Phase 31
Showing 1–8 of 8 trials
Recruiting
Phase 2
Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma
Mesenchymal Chondrosarcoma
Italian Sarcoma Group16 enrolled7 locationsNCT04305548
Recruiting
Phase 2
Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma
Soft Tissue SarcomaLeiomyosarcoma of Ovary
Italian Sarcoma Group100 enrolled17 locationsNCT04383119
Recruiting
Phase 2
Phase II Decentralized Pragmatic Trial of Adjuvant Doxorubicin - Trabectedin Chemotherapy in uLMS
Uterine Leiomyosarcoma
M.D. Anderson Cancer Center48 enrolled1 locationNCT07076186
Recruiting
Phase 3
tTF-NGR Randomized Study - STS
Soft Tissue Sarcoma
Universität Münster126 enrolled9 locationsNCT05597917
Recruiting
Phase 2
Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour
Leiomyosarcoma Uterus
UNICANCER198 enrolled25 locationsNCT06524583
Recruiting
Phase 2
Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma
Leiomyosarcoma
Sarcoma Oncology Research Center, LLC80 enrolled1 locationNCT04535271
Recruiting
Phase 1Phase 2
SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma
Metastatic Soft Tissue SarcomaAdvanced Soft Tissue Sarcoma
Sarcoma Oncology Research Center, LLC250 enrolled1 locationNCT03138161
Recruiting
Phase 1Phase 2
Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients
Liposarcoma, Myxoid
Grupo Espanol de Investigacion en Sarcomas199 enrolled17 locationsNCT02275286